Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Pharmaceutical Research|April 28, 2010
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerSanjeev Banerjee, Asfar S Azmi, Subhash Padhye, et al.
American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.
Cancer Metastasis Reviews|September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizonSahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.
Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.
Current Oncology (Toronto, Ont.)|November 24, 2022
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel CombinationAmr Mohamed, Asfar S Azmi, Sylvia L Asa, et al.
Oncogene|September 7, 2010
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapyA S Azmi, P A Philip, F W J Beck, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challengesKhalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.
Pageof 19